145 related articles for article (PubMed ID: 35096810)
1. Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer.
Shen A; Liu L; Huang Y; Shen Z; Wu M; Chen X; Wu X; Lin X; Chen Y; Li L; Cheng Y; Chu J; Sferra TJ; Wei L; Zhuang Q; Peng J
Front Cell Dev Biol; 2021; 9():772077. PubMed ID: 35096810
[No Abstract] [Full Text] [Related]
2. Transcription Factor EBF1 Over-Expression Suppresses Tumor Growth
Shen Z; Chen Y; Li L; Liu L; Peng M; Chen X; Wu X; Sferra TJ; Wu M; Lin X; Cheng Y; Chu J; Shen A; Peng J
Front Oncol; 2020; 10():1035. PubMed ID: 32676457
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer.
Liu L; Chen Y; Lin X; Wu M; Li J; Xie Q; Sferra TJ; Han Y; Liu H; Cao L; Yao M; Peng J; Shen A
Cancer Cell Int; 2021 Oct; 21(1):547. PubMed ID: 34663329
[TBL] [Abstract][Full Text] [Related]
5. Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer Cells.
Shen A; Wu M; Liu L; Chen Y; Chen X; Zhuang M; Xie Q; Cheng Y; Li J; Shen Z; Wei L; Chu J; Sferra TJ; Zhang X; Xu N; Li L; Peng J; Chen F
Front Oncol; 2021; 11():681425. PubMed ID: 34367967
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
7. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
8. Berbamine suppresses cell viability and induces apoptosis in colorectal cancer via activating p53-dependent apoptotic signaling pathway.
Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
Cytotechnology; 2018 Feb; 70(1):321-329. PubMed ID: 28965196
[TBL] [Abstract][Full Text] [Related]
9. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-Like Protein UBD Promotes Cell Proliferation in Colorectal Cancer by Facilitating p53 Degradation.
Su H; Qin M; Liu Q; Jin B; Shi X; Xiang Z
Front Oncol; 2021; 11():691347. PubMed ID: 34350116
[TBL] [Abstract][Full Text] [Related]
11. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
[TBL] [Abstract][Full Text] [Related]
12. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) promote cell proliferation in colorectal cancer by affecting P53.
Zhao Y; Qin ZS; Feng Y; Tang XJ; Zhang T; Yang L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):976-984. PubMed ID: 29509245
[TBL] [Abstract][Full Text] [Related]
14. Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression.
Li M; Deng Y; Zhuo M; Zhou H; Kong X; Xia X; Su Z; Chen Q; Guo P; Mo P; Yu C; Li W
Theranostics; 2020; 10(19):8863-8879. PubMed ID: 32754284
[No Abstract] [Full Text] [Related]
15. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal protein S15A promotes malignant transformation and predicts poor outcome in colorectal cancer through misregulation of p53 signaling pathway.
Chen J; Wei Y; Feng Q; Ren L; He G; Chang W; Zhu D; Yi T; Lin Q; Tang W; Xu J; Qin X
Int J Oncol; 2016 Apr; 48(4):1628-38. PubMed ID: 26847263
[TBL] [Abstract][Full Text] [Related]
18. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.
Zhou S; Lu J; Li Y; Chen C; Cai Y; Tan G; Peng Z; Zhang Z; Dong Z; Kang T; Tang F
J Exp Clin Cancer Res; 2018 Nov; 37(1):284. PubMed ID: 30477538
[TBL] [Abstract][Full Text] [Related]
19. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
20. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
